Opioid Addiction in Pregnancy: Does Depression Negatively Impact Adherence With Prenatal Care?

Area of Science:

• Obstetrics and Gynecology
• Perinatal Mental Health
• Addiction Medicine

Background:

• Opioid dependency during pregnancy presents complex challenges for both maternal and fetal health.
• Co-occurring depression is common in pregnant women with opioid use disorder, potentially complicating treatment and outcomes.

Purpose of the Study:

• To investigate the impact of depression on prenatal care adherence in pregnant women with opioid dependency.
• To assess the association between depression and neonatal outcomes, including neonatal abstinence syndrome (NAS) and neonatal intensive care unit (NICU) stays.

Main Methods:

• Retrospective chart analysis of 74 opioid-dependent pregnant women over a 6-year period.
• Primary outcome: prenatal care adherence, measured by observed vs. expected visits.
• Secondary outcomes: NICU stay duration, NAS incidence and severity, comparing depression diagnosis groups and different maintenance therapies.

Main Results:

• Women diagnosed with depression showed significantly lower adherence to prenatal care (e.g., 73% vs. 93% adherence at 80% expected visits, P=0.03).
• The depression group experienced a higher incidence of infant treatment for withdrawal (62% vs. 38%, P=0.041) and longer NICU stays (27% vs. 21%, P=0.018).
• Buprenorphine maintenance therapy was associated with the lowest mean NAS scores (6.5 ± 4.4) compared to methadone (10.6 ± 3.6) and no maintenance therapy (9.4 ± 4.0).

Conclusions:

• Depression significantly impairs prenatal care adherence in opioid-dependent pregnant women.
• Depression is linked to increased neonatal withdrawal symptoms and extended NICU hospitalizations.
• Buprenorphine therapy demonstrates superior outcomes in reducing NAS severity compared to methadone or no maintenance therapy.